
Publikationen von Andreas Menke
Alle Typen
Zeitschriftenartikel (52)
1.
Zeitschriftenartikel
19, 61 (2018)
Correction to: Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling (vol 16, 266, 2015). GENOME BIOLOGY 2.
Zeitschriftenartikel
69, S. 161 - 171 (2016)
Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests. PSYCHONEUROENDOCRINOLOGY 3.
Zeitschriftenartikel
16, 266 (2015)
Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling. GENOME BIOLOGY 4.
Zeitschriftenartikel
57, S. 1 - 13 (2015)
An analysis of gene expression in PTSD implicates genes involved in the glucocorticoid receptor pathway and neural responses to stress. PSYCHONEUROENDOCRINOLOGY 5.
Zeitschriftenartikel
86 (5), S. 1189 - 1202 (2015)
Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders. NEURON 6.
Zeitschriftenartikel
44, S. 35 - 46 (2014)
Dexamethasone stimulated gene expression in peripheral blood indicates glucocorticoid-receptor hypersensitivity in job-related exhaustion. PSYCHONEUROENDOCRINOLOGY 7.
Zeitschriftenartikel
83 (2), S. 344 - 360 (2014)
MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity. NEURON 8.
Zeitschriftenartikel
16 (3), S. 395 - 404 (2014)
Epigenetic alterations in depression and antidepressant treatment. Dialogues in clinical neuroscience 9.
Zeitschriftenartikel
25 (5), S. 579 - 591 (2013)
Gene expression: Biomarker of antidepressant therapy? INTERNATIONAL REVIEW OF PSYCHIATRY 10.
Zeitschriftenartikel
8 (6), e64947 (2013)
Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach. PLOS ONE 11.
Zeitschriftenartikel
18 (36), S. 5879 - 5889 (2012)
Epigenetics, Depression and Antidepressant Treatment. Current Pharmaceutical Design 12.
Zeitschriftenartikel
37 (6), S. 1455 - 1464 (2012)
Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients. Neuropsychopharmacology 13.
Zeitschriftenartikel
37 (4), S. 565 - 575 (2012)
Polymorphisms within the metabotropic glutamate receptor 1 gene are associated with depression phenotypes. Psychoneuroendocrinology 14.
Zeitschriftenartikel
37 (3), S. 797 - 807 (2012)
Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation. Neuropsychopharmacology 15.
Zeitschriftenartikel
124 (4), S. 317 - 328 (2011)
Somatization in major depression - clinical features and genetic associations. Acta Psychiatrica Scandinavica 16.
Zeitschriftenartikel
44 (6), S. 295 - 295 (2011)
BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry 17.
Zeitschriftenartikel
68 (9), S. 901 - 910 (2011)
Using Polymorphisms in FKBP5 to Define Biologically Distinct Subtypes of Posttraumatic Stress Disorder Evidence From Endocrine and Gene Expression Studies. Archives of General Psychiatry 18.
Zeitschriftenartikel
44 (6), S. 300 - 300 (2011)
Gender related differential response to dexamethasone in endocrine and immune measures in depressed patients and healthy controls. Pharmacopsychiatry 19.
Zeitschriftenartikel
21 (Suppl. 3), S. S248 - S249 (2011)
Glucocorticoid induced FKBP5-gene expression in depressed patients and healthy controls. European Neuropsychopharmacology 20.
Zeitschriftenartikel
44 (6), S. 308 - 308 (2011)
Effectiveness of a standardized cognitive training in depression and the interaction with HPA-axis regulation. Pharmacopsychiatry